This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Shannon, K. M. Articles by Matthay, K. K. Search for Related Content PubMed Articles by Shannon, K. M. Articles by Matthay, K. K. Social Bookmarking                         What's this?

Pediatric Bone Marrow Transplantation: Intensive Care Management

Department of Pediatrics, University of California School of Medicine, San Francisco, CA, Clinical Investigation Center, United States Naval Hospital, Oakland, CA

Morton J. Cowan

Department of Pediatrics, University of California School of Medicine, San Francisco, CA, Clinical Investigation Center, United States Naval Hospital, Oakland, CA

Katherine K. Matthay

Department of Pediatrics, M-650, UCSF School of Medicine, San Francisco, CA 94143.

Bone marrow transplantation (BMT) has assumed in creasing importance in the treatment of bone marrow failure, hematopoietic malignancies, congenital immuno deficiencies, and solid tumors. Children undergoing BMT are at high risk for infection and hemorrhage dur ing the period of aplasia. In addition, life-threatening complications of circulatory, pulmonary, gastrointesti nal, hepatic, and renal function are common and fre quently require intensive supportive care. This review provides an overview of pediatric BMT that focuses on management problems relevant to intensive care. Thor ough pretransplantation assessment of underlying organ dysfunction is mandatory before undertaking BMT. The complications associated with preconditioning regi mens that use total body irradiation and high doses of ablative chemotherapy are described. Finally, problems involving individual organs are discussed by systems. The challenge of improving the results of BMT in the treatment of childhood malignant and hematopoietic disorders depends, in large part, on successful preven tive measures and good management of complications that occur immediately before and within the first 100 days after transplantation. As BMT is indicated for treat ment of an increasing number of diseases, more patients will require the care of intensivists familiar with trans plantation-related complications.

Journal of Intensive Care Medicine, Vol. 2, No. 6, 328-344 (1987)
DOI: 10.1177/088506668700200605


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?